Clinic Software← All companies
Yaso Therapeutics (United States)
Contraception without the side effects of pills, devices, or implants
health AI/medtech/pharmaceuticals (biotech/pharma startup in contraception and antimicrobial platform)
StageGrant-funded / Business Plan Competition winner
Raised$7,385,838
Founded2004
Employees3
LocationFrisco, TX
Business modelB2B/B2C (not explicitly stated), likely research/drug platform development with potential licensing or partnerships
About
Yaso Therapeutics develops a non-hormonal contraceptive gel using its patented PPCM drug platform, currently in Phase 1 clinical trials. The multipurpose platform uses nanoscale delivery to create a barrier against viruses and bacteria, with potential activity against drug-resistant pathogens and STDs. The company aims to provide contraception without the side effects associated with pills, devices, or implants.
Product
- Value proposition
- A new multi-purpose drug platform (PPCM) and Yaso Gel aiming to provide non-hormonal contraception and broad antimicrobial protection using nanotechnology, with Phase 1 clinical trials.
- Regulatory
- Phase 1 clinical trial
Founders
- Mary Weitzel
- Barbara North
Categories
Products
PPCM drug platformYaso Gel
Key features
Non-hormonal contraceptionMultipurpose drug platformNanoscale deliveryBarrier-forming mechanism against virusesPotential antiviral/antibacterial activity
Technologies
NanotechnologyDrug development platformBarrier formation
Target conditions
Contraception (non-hormonal)Drug-resistant pathogens (broad antimicrobial activity)Viral and bacterial infections
Care settings
clinical trial site (Phase 1)research laboratory
Traction metrics
Phase 1 clinical trial status
Investors
NIAIDHHSMedCity INVESTSpringboard Enterprises
News
- Yaso’s CEO Wins Startup Championship — Yaso Therapeutics · 2025-09-23T14:19:21.000Z
- YASO GEL in Early-phase Safety and PK Study of a Vaginal Gel - Clinical Trials Registry - ICH GCP · 2025-12-10T00:00:00.000Z
- Who Won MedCity INVEST Pitch Perfect? - MedCity News · 2025-05-22T21:39:09.000Z
- Mary Weitzel · 2026-06-07T06:15:40.000Z
- IASO Therapeutics Synthetic Vaccine- MSU Innovation Center · 2025-11-29T18:46:36.000Z
- Iaso Therapeutics Develops Next Generation of Vaccines - Iaso Therapeutics · 2026-02-09T19:39:41.000Z
